Scarica l'app Stockscreener
22.53
0.49%
-0.11
Dopo l'orario di chiusura:
22.53
Precedente Chiudi:
$22.64
Aprire:
$22.58
Volume 24 ore:
503.43K
Relative Volume:
0.72
Capitalizzazione di mercato:
$733.48M
Reddito:
$796.33M
Utile/perdita netta:
$74.95M
Rapporto P/E:
11.03
EPS:
2.0427
Flusso di cassa netto:
$329.83M
1 W Prestazione:
-1.05%
1M Prestazione:
-17.98%
6M Prestazione:
-32.24%
1 anno Prestazione:
-34.98%
Intervallo 1D:
$22.29
$22.91
Intervallo di 1 settimana:
$21.77
$23.69
Portata 52W:
$21.65
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, TEVA, HLN, ZTS, VTRS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
22.53 | 733.48M | 796.33M | 74.95M | 329.83M | 2.0427 |
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - Yahoo Finance UK
Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - Yahoo! Finance Canada
Collegium Pharmaceutical stock falls 1.45 percent near yearly low - AD HOC NEWS
Collegium Pharmaceutical Price Target Announced at $50.00/Share by Oppenheimer - Moomoo
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform By Investing.com - Investing.com South Africa
Oppenheimer initiates Collegium Pharmaceutical stock at Outperform - Investing.com
Oppenheimer Initiates Collegium Pharmaceutical at Outperform With $50 Price Target - Yahoo Finance
Collegium Pharmaceutical stock holds as market data show no catalyst - AD HOC NEWS
Collegium Pharmaceutical stock edges lower as analysts keep Moderate Buy stance - AD HOC NEWS
Collegium Pharmaceutical at H.C. Wainwright: pushing beyond pain By Investing.com - Investing.com Nigeria
Collegium Pharmaceutical at H.C. Wainwright: pushing beyond pain - Investing.com
Leerink Partners Initiates Collegium Pharmaceutical(COLL.US) With Buy Rating, Announces Target Price $45 - Moomoo
(COLL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical stock edges higher after recent quarterly update - AD HOC NEWS
Collegium Pharmaceutical Inc. (COLL) Peer Comparison – Compare with Others - Value Research
Collegium Pharmaceutical Inc. (COLL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
(COLL) Risk Channels and Responsive Allocation - Stock Traders Daily
A Look at Collegium Pharmaceutical Inc (COLL) After 3.9% Decline -- GF Value $47.17 vs Price $26.39 - GuruFocus
Israel A. Englander reports new Collegium (NASDAQ: COLL) stake - Stock Titan
Collegium (COLL) Move: Ends Higher by 2.18% at $27.70 in Latest Trading; Technical View: the $26.31 to $29.09 Range Remains in Focus in the Latest SessionETF NAV Deviation - vinanet.vn
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Cuts Target Price to $48 - Moomoo
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call - Yahoo Finance
Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock - Stock Titan
Collegium Pharmaceutical stock jumps on $50M share buyback - Investing.com
COLLEGIUM PHARMACEUTICAL INC : NEEDHAM CUTS TARGET PRICE TO $46 FROM $56 - webull.com
Can Collegium Pharmaceutical (NASDAQ:COLL) Rebound From Its Yearly Low? - Kalkine Media
Collegium Pharmaceutical Initiates $50 Million Accelerated Share Buyback with Jefferies LLC - Kalkine Media
Collegium Pharmaceutical stock jumps on $50M share buyback By Investing.com - Investing.com Canada
Why is Collegium Pharmaceutical stock climbing today? By Investing.com - Investing.com Canada
Collegium Pharmaceutical Launches $50 Million Accelerated Share Repurchase Program - citybiz
Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Collegium Pharmaceutical to repurchase $50 million in stock By Investing.com - Investing.com Nigeria
Collegium gains on accelerated share buybacks (COLL:NASDAQ) - Seeking Alpha
Collegium Pharmaceutical to repurchase $50 million in stock - Investing.com
Collegium Pharmaceutical launches $50M accelerated share repurchase under $150M buyback program - TradingView
Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewswire
Collegium Pharmaceutical (NASDAQ:COLL) Sets New 1-Year LowTime to Sell? - MarketBeat
Collegium Pharmaceutical Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Collegium Pharmaceutical (COLL) Slips 0.85% While Holding Above Key Support at $25.62Value ETF - careplusvn.com
Collegium Pharmaceutical (NASDAQ:COLL) Shares Down 6.5%Here's What Happened - MarketBeat
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance - Yahoo Finance
Collegium Pharmaceutical, Inc. Revenue Breakdown – NASDAQ:COLL - TradingView
Collegium Pharmaceutical (COLL) Stock Revenue Growth Masks Deepening Margin Squeeze - simplywall.st
Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at Wall Street Zen - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Releases Earnings Results, Beats Estimates By $0.20 EPS - MarketBeat
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Cuts Target Price to $43 - Moomoo
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.18%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):